CloudMD will implement its telehealth technology across clinic network Digital healthcare and telemedicine are the great equalizer for healthcare delivery; demand is surging and part of the new normal. The U.S. recently has made swift […]
Teladoc Health, Inc. (NYSE: TDOC) Q2 2020 Earnings Call Highlights Jason Gorevic, CEO “…We reported the results of our second quarter, 2020, which was characterized by outperformance across all key financial and operational metrics driven […]
(OTC: DOCRF) NEXT SUPER STOCK CEO Interview & Investor LiveChat: July 31, 2020 (OTC: DOCRF) NEXT SUPER STOCK conference presentation: July 29, 2020 ABOUT THE EVENT NEXT SUPER STOCK Live! is Wall Street Reporter’s flagship investor […]
NEXT SUPER STOCK – July 29, 2020 Livestream Valeo Pharma (CSE: VPH) CEO Steve Saviuk presented at Wall Street Reporter’s NEXT SUPER STOCK livestream event on July 29. Valeo is a specialty pharmaceutical company dedicated to the […]
MONTREAL, July 29, 2020 – Valeo Pharma Inc. (CSE: VPH) (“Valeo” or the “Company“), a Canadian specialty pharmaceutical company, announced today that it has completed and filed its application to list the Company’s Class A shares (“Shares”) […]
Cash flow positive medical clinic with 12 physicians servicing over 60,000 patients VANCOUVER, British Columbia, July 28, 2020 — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a […]
A silent mental health crisis existed before the COVID-19 pandemic and has now been brought to the forefront as a crisis on its own. COVID 19 has created a global focus on mental and physical […]
AmetopTM commercialization to begin in July 2020 First of four Valeo products scheduled for launch this summer MONTREAL , July 13, 2020 – Valeo Pharma Inc. (VPH.CN) (“Valeo” or the “Company“), a Canadian specialty pharmaceutical company, announced today […]
VANCOUVER, Washington, May 18, 2020 — Three arms of this trial will be leronlimab, remdesivir, and leronlimab + remdesivir CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), […]
VANCOUVER, Washington, May 15, 2020– CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced it is […]
Next Super Stock – May 13, 2020 Livestream Wall Street Reporter’s NEXT SUPER STOCK livestream presentation May 13, 2020. CytoDyn (OTC: CYDY) CEO Dr. Nader Pourhassan, Ph.D. joined by CytoDyn’s medical advisor, Dr. Bruce Patterson, […]
SAN DIEGO, May 5, 2020 —- Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc., […]
54 eINDs approved by FDA and 49 patients have been treated with leronlimab thus far VANCOUVER, Washington, Apr 30, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab […]
Company appoints Interim Chief Financial Officer VANCOUVER, Washington, Apr 27, 2020 — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for […]
VANCOUVER, Washington, Apr 27, 2020 — During the FDA’s review period, the Company will dedicate all resources to ensure availability of leronlimab for COVID-19 patients; Cancer programs continue with positive results VANCOUVER, Washington, April 27, 2020 […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
